Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 1
2009 3
2010 5
2011 3
2012 3
2013 4
2014 2
2016 2
2017 2
2018 5
2019 4
2020 4
2021 7
2022 6
2023 3
2024 6
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Coxsackie B3-induced rhombencephalitis.
Molimard J, Baudou E, Mengelle C, Sevely A, Cheuret E. Molimard J, et al. Among authors: cheuret e. Arch Pediatr. 2019 May;26(4):247-248. doi: 10.1016/j.arcped.2019.02.013. Epub 2019 Mar 9. Arch Pediatr. 2019. PMID: 30862394 No abstract available.
Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.
Chitnis T, Arnold DL, Banwell B, Brück W, Ghezzi A, Giovannoni G, Greenberg B, Krupp L, Rostásy K, Tardieu M, Waubant E, Wolinsky JS, Bar-Or A, Stites T, Chen Y, Putzki N, Merschhemke M, Gärtner J; PARADIGMS Study Group. Chitnis T, et al. N Engl J Med. 2018 Sep 13;379(11):1017-1027. doi: 10.1056/NEJMoa1800149. N Engl J Med. 2018. PMID: 30207920 Free article. Clinical Trial.
Long-Term Clinical and Biological Prognostic Factors of Anti-NMDA Receptor Encephalitis in Children.
Mazowiecki M, Flet-Berliac L, Roux J, Lépine A, Chretien P, Hacein-Bey-Abina S, Giorgi L, Villega F, Cheuret E, Benaiteau M, Rogemond V, Picard G, Baer S, Cleuziou P, Lametery E, Desguerre I, Aubart M, Chevignard M, Le Grand R, Horellou P, Leroy C, Joubert B, Honnorat J, Deiva K. Mazowiecki M, et al. Among authors: cheuret e. Neurol Neuroimmunol Neuroinflamm. 2025 Mar;12(2):e200346. doi: 10.1212/NXI.0000000000200346. Epub 2024 Dec 23. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 39715492 Free PMC article.
Adjunctive dexamethasone and 30-day all-cause death after hospital admission in paediatric pneumococcal meningitis: a propensity score analysis.
Giolito A, Levy C, Varon E, Cohen R, Hanna S, Assad Z, Lenglart L, Bechet S, Bonacorsi S, Dubos F, Launay E, Pelleter M, Rybak A, Angoulvant F, Levy M, Ouldali N; French Paediatric Meningitis Network. Giolito A, et al. Lancet Child Adolesc Health. 2025 Apr;9(4):255-261. doi: 10.1016/S2352-4642(25)00029-X. Lancet Child Adolesc Health. 2025. PMID: 40113367
French guidelines for the diagnosis and management of MOG antibody-associated disease.
Giorgi L, Marignier R, Pique J, Maurey H, Papeix C, Ciron J, Collongues N, Cheuret E, Zephir H, Meyer P, Vukusic S, Doret-Dion M, Abi Warde MT, Poulat AL, Barreau E, Deschamps R, Audoin B, Mannes I, Yver E, Lattaud C, Maillart E, Deiva K; MIRCEM network. Giorgi L, et al. Among authors: cheuret e. Rev Neurol (Paris). 2025 Sep;181(7):597-607. doi: 10.1016/j.neurol.2025.04.012. Epub 2025 Jun 9. Rev Neurol (Paris). 2025. PMID: 40494723 Free article.
Refined genotype-phenotype correlations in neurofibromatosis type 1 patients with NF1 point variants.
Pacot L, Blok M, Vidaud D, Fertitta L, Laurendeau I, Coustier A, Maillard T, Barbance C, Hadjadj D, Ye M, Lallemand D, Ferkal S, Funalot B, Lunati-Rozie A, Hebrard B, Bhouri R, Spruijt L, Bessis D, Geneviève D, Vernimmen V, Broen MPG, Sigaudy S, Odent S, Damaj L, Quélin C, Pasquier L, Layet V, Gilbert-Dussardier B, Nicolas G, Guerrot AM, Leheup B, Bursztejn AC, Petit F, Boute-Bénéjean O, Capri Y, Guimier A, Lyonnet S, Baujat G, Bourrat E, Isidor B, Nizon M, Barbarot S, Toutain A, Blesson S, Van-Gils J, Morice-Picard F, Audebert-Bellanger S, Mazereeuw-Hautier J, Ziegler A, Alembik Y, Piard J, Brischoux-Boucher E, Guerrini-Rousseau L, Morera J, Paquis-Flucklinger V, Delobel B, Alessandri JL, Parfait B; NF-France network; Wolkenstein P, Pasmant E. Pacot L, et al. J Med Genet. 2025 Aug 28:jmg-2025-110783. doi: 10.1136/jmg-2025-110783. Online ahead of print. J Med Genet. 2025. PMID: 40759488 Free article.
Long-term outcome of paediatric anti-N-methyl-D-aspartate receptor encephalitis.
Flet-Berliac L, Tchitchek N, Lépine A, Florea A, Maurey H, Chrétien P, Hacein-Bey-Abina S, Villega F, Cheuret E, Rogemond V, Picard G, Honnorat J, Deiva K. Flet-Berliac L, et al. Among authors: cheuret e. Dev Med Child Neurol. 2023 May;65(5):691-700. doi: 10.1111/dmcn.15429. Epub 2022 Oct 5. Dev Med Child Neurol. 2023. PMID: 36196688 Free article.
Long-term outcomes of paediatric Guillain-Barré syndrome.
Estublier B, Colineaux H, Arnaud C, Cintas P, Baudou E, Chaix Y, Rivier F, Biotteau M, Meyer P, Cheuret E. Estublier B, et al. Among authors: cheuret e. Dev Med Child Neurol. 2024 Feb;66(2):176-186. doi: 10.1111/dmcn.15693. Epub 2023 Jul 27. Dev Med Child Neurol. 2024. PMID: 37501281 Free article.
Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1.
Pacot L, Sabbagh A, Sohier P, Hadjadj D, Ye M, Boland-Auge A, Bacq-Daian D, Laurendeau I, Briand-Suleau A, Deleuze JF, Margueron R, Vidaud M, Ferkal S, Parfait B, Vidaud D; NF-France Network; Pasmant E, Wolkenstein P. Pacot L, et al. Br J Dermatol. 2024 Jan 23;190(2):226-243. doi: 10.1093/bjd/ljad390. Br J Dermatol. 2024. PMID: 37831592
59 results